Screener
Beta Bionics BBNX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Beta Bionics’s reported figures.
Based on trailing twelve months.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
FAQ
- What is Beta Bionics's free cash flow margin?
- Beta Bionics (BBNX) reported free cash flow margin of -51.6% in Q2 2026.
- How has Beta Bionics's free cash flow margin changed year-over-year?
- Beta Bionics's free cash flow margin increased by 35.1% year-over-year, from -79.5% to -51.6%.
- What is the long-term trend for Beta Bionics's free cash flow margin?
- Over 2 years (2023 to 2025), Beta Bionics's free cash flow margin has grown at a -54.7% compound annual growth rate (CAGR), from -273.8% to -56.1%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Beta Bionics's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude